The statement below was issued on 12 March 2015:
In addition to today’s news of continued expansion into the Asian market, Admedus announced that it is on track for the strongest quarter of CardioCel® sales, building on the foundation of key, global centre use that has been established over the past year."
|Given that the revenue for the 2nd quarter was $2.5 million, then if the above statement was correct, then sales of other products have declined significantly as the receipts were approximately $400k under the 2nd quarter with revenue static. No surprise that the market reacted with a 3.8% decrease.
The company owes its shareholders more frequent updates on the revenues and the breakdown of the revenue figures.
- Forums
- ASX - By Stock
- Quarterly
The statement below was issued on 12 March 2015: In addition to...
-
- There are more pages in this discussion • 91 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$15.00 |
Change
0.150(1.01%) |
Mkt cap ! $317.0M |
Open | High | Low | Value | Volume |
$15.00 | $15.15 | $14.30 | $210.2K | 14.26K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500 | $14.60 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.00 | 5153 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500 | 14.600 |
1 | 60 | 14.350 |
1 | 40 | 14.320 |
1 | 38 | 14.260 |
1 | 200 | 14.200 |
Price($) | Vol. | No. |
---|---|---|
15.000 | 5153 | 3 |
15.150 | 204 | 1 |
15.350 | 2000 | 1 |
15.500 | 44 | 1 |
16.030 | 999 | 1 |
Last trade - 16.10pm 14/08/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |